Creative Planning’s Immunic IMUX Stock Holding History

Creative Planning’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$38.9K	Buy	3,502 +2	+0.1%	+$18	﹤0.01%	4008
2025 Q4	$18.7K	Hold	3,500	–	–	﹤0.01%	3850
2025 Q3	$30.9K	Hold	3,500	–	–	﹤0.01%	3789
2025 Q2	$24.4K	Hold	3,500	–	–	﹤0.01%	3584
2025 Q1	$38.1K	Hold	3,500	–	–	﹤0.01%	3367
2024 Q4	$35K	Buy	+3,500	New	+$44.1K	﹤0.01%	3289
2017 Q3	–	Sell	-2	Closed	-$2K	–	2761
2017 Q2	$2K	Hold	2	–	–	﹤0.01%	4306
2017 Q1	$3K	Hold	2	–	–	﹤0.01%	4163
2016 Q4	$3K	Hold	2	–	–	﹤0.01%	4148
2016 Q3	$4K	Hold	2	–	–	﹤0.01%	3976
2016 Q2	$4K	Hold	2	–	–	﹤0.01%	3747
2016 Q1	$6K	Buy	+2	New	+$6.95K	﹤0.01%	3495
2015 Q4	–	Sell	-11	Closed	-$18K	–	4484
2015 Q3	$18K	Buy	+11	New	+$55K	﹤0.01%	2802

Other funds holding IMUX

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Creative Planning's IMUX Position: Q1 2026 in Review

Creative Planning increased its Immunic (IMUX) stake by 0.06% in Q1 2026, buying an estimated $18 and bringing the position to 3,502 shares worth $38.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4008.

Creative Planning first reported a position in IMUX in Q3 2015 and has held it in 13 quarters since. 75 funds tracked by Wall St. Rank hold IMUX as of Q1 2026.

Creative Planning held 3,502 shares of Immunic worth $38.9K as of Q1 2026.
Creative Planning bought 2 Immunic shares in Q1 2026, an estimated $18.
Immunic made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #4008 holding.
Creative Planning first reported a position in Immunic in Q3 2015 and has held it in 13 quarters since.
75 funds tracked by Wall St. Rank held Immunic as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.